➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Colorcon
Boehringer Ingelheim
Baxter
McKesson

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Litigation Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-03-23
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Douglas E. Arpert
Parties EMCURE PHARMACEUTICALS USA, INC.; EMCURE PHARMACEUTICALS LIMITED; EXELA HOLDINGS, INC.; EXELA PHARMA SCIENCES, LLC; EXELA PHARMSCI, INC.; FRESENIUS KABI USA, LLC; HELSINN HEALTHCARE S.A.; HOSPIRA WORLDWIDE, INC.; HOSPIRA, INC.; ROCHE PALO ALTO LLC
Patents 6,063,802; 6,132,758; 6,284,770; 6,294,548; 7,947,724; 7,947,725; 7,960,424; 8,518,981; 8,598,219; 8,729,094
Attorneys ALLISON LINDA HOLLOWS; ANGELA CHERYL NI; ARNOLD B. CALMANN; CHARLES MICHAEL LIZZA; DAVID C. KISTLER; ERIC W. DITTMANN; GARY J. RUCKELSHAUS; ISAAC SAMUEL ASHKENAZI; JEFFREY S. SOOS; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; LEE A. GOLDBERG; SARAH ANN SULLIVAN; STEVEN JAMES LINK; WILLIAM C. BATON
Firms Blank Rome LLP; Fox Rothschild LLP; Fox Rothschild LLP, Pc; Heritage Pharmaceuticals Inc.; Merchant & Gould Pc
Link to Docket External link to docket
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. HOSPIRA, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-03-23 1 , 5,622,720, 5,955,488, and 6,063,802. Commer- rently pending U.S. patent application Ser. No. 11/186,311…Rancate (CH); 6,063,802 A 5/2000 Winterborn . … 5,922,749, 5,622,720, 5,955,488, and 6,063,802. Commer- ence. …Winterborn . 514/399 6,063,802 A 5/2000 Winterborn . …Winterborn . 514/399 6,063,802 A 5/2000 Winterborn . External link to document
2016-04-05 86 United States Patent No. 7,947,724 (“the ‘724 patent”), No. 7,947,725 (“the ‘725 patent”), No. 7,960,…“the ‘424 patent”), No. 8,598,219 (“the ‘219 patent”), and No. 8,729,094 (“the ‘094 patent”) (collectively…other assignee of the Aloxi® patents. (See dkt. 22 at 6.) The Aloxi® patents claim various formulations…Aloxi® patents; (2) Defendants’ paragraph IV notice letter allegations that the Aloxi® patents are invalid…(b) of the Patent Act provides that: “Whoever actively induces infringement of a patent shall be liable External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
AstraZeneca
Moodys
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.